Is Magnetic Resonance Spectroscopy the new gold standard for breast cancer diagnosis?
Mountford, Carolyn E × Malycha, Peter Lean, Cynthia L Somorjai, Ray L Tomanek, Bogoslaw Gluch, Lawrence Russell, Peter Gillett, David Doran, Sinead Himmelreich, Uwe Stanwell, Peter #
European radiology vol:13 issue:9 pages:D47-D49
Aims: A. Use robust classification methods to analyse magnetic resonance spectroscopy (MRS) data at 8.5 Tesla (T) of fine needle aspirate biopsies (FNAB) taken from breast tumours. The resultant data, when compared with the histopathology and clinical criteria, would provide computerised classification-based diagnosis and prognosis with a high degree of accuracy and reliability.
B. Develop MR hardware and software required for use of the
MRS technology in routine clinical/diagnostic settings and document avenues for acceptance testing at clinical sites.
C. Develop the MRS methodology to determine the pathology for a breast lesion non-invasively in vivo at 1.5 T.